Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 2
1981 5
1982 3
1983 1
1984 2
1985 5
1986 5
1987 10
1988 9
1989 9
1990 18
1991 29
1992 25
1993 30
1994 29
1995 48
1996 29
1997 49
1998 52
1999 53
2000 62
2001 62
2002 73
2003 109
2004 123
2005 146
2006 203
2007 249
2008 288
2009 294
2010 368
2011 388
2012 462
2013 621
2014 687
2015 855
2016 893
2017 985
2018 1155
2019 1269
2020 1520
2021 1888
2022 2185
2023 2093
2024 2367
2025 2869
2026 1835

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,875 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hou m.[Author] (4,352 results)?
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.
Lu S, Liu B, Luo Y, Sun L, Wu L, Han Z, Fan Y, Zhao Y, Li X, Xu H, Meng X, Liu Y, Zhang Z, Luo H, Ma X, Ma X, Shi Q, Zhang Z, Yang R, Wang P, Pan P, Ai X, Li J, Pu X, Wang Z, Fang J, He M, He Y, Guo S, Li J, Wang H, Zhang J, Chu Q, Liu X, Ying S, Wu H, Sun H, Ji Y, Zhou M, Cao C, Tang K, Li Z, Li D, Zhang Z, Li J, Zhou J, Yang H, Du Y, Yang H, Shi J, Chen H, Chen Z, Li W, Lu D, Hu M, Wang ZM, Li B, Xia MY. Lu S, et al. Among authors: zhou m. Lancet. 2026 Jun 27;407(10548):2620-2629. doi: 10.1016/S0140-6736(26)00966-9. Epub 2026 May 31. Lancet. 2026. PMID: 42218899 Clinical Trial.
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial.
Xiong A, Yao W, Zheng W, Yu Y, Chen P, Zhong H, Ge J, Wang H, Chen B, Wang H, Fan Y, Yang Y, Pu X, Song X, Wang Q, Du X, Huang Z, Li X, Luo H, Yao Y, Yu Q, Su C, He L, Jiang G, Cui J, Liu C, Yi T, Che G, Liu Z, Zhang L, Zhou M, Fang Y, Wei Y, Qing Y, Jin X, Zhou C. Xiong A, et al. Among authors: zhou m. Lancet. 2026 Jun 27;407(10548):2607-2619. doi: 10.1016/S0140-6736(26)00968-2. Epub 2026 May 29. Lancet. 2026. PMID: 42214392 Clinical Trial.
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial.
HARMONi-A Study Investigators; Fang W, Zhao Y, Luo Y, Yang R, Huang Y, He Z, Zhao H, Li M, Li K, Song Q, Du X, Sun Y, Li W, Sun L, Wang Z, Yang K, Fan Y, Liu B, Zhao H, Hu Y, Jia L, Xu S, Yi T, Lv D, Lan H, Li M, Liang W, Wang Y, Yang H, Jia Y, Chen Y, Lu J, Shi M, Liu C, Zhou M, Zhou J, Liu X, Zhou N, He M, Dong X, Chen H, Chen Y, Su H, Li X, Zhang Z, Yang L, Liu Y, Chen L, Hou X, Zhang Y, Guo J, Ma R, Lu H, Wu D, Feng W, Li W, Huang J, Wang Y, Song X, Peng J, Liu L, Guo Y, Li W, Xia M, Lu D, Hu M, Wang ZM, Li B, Xia MY, Zhang L. HARMONi-A Study Investigators, et al. Among authors: zhou m. JAMA. 2026 Jun 17:e267745. doi: 10.1001/jama.2026.7745. Online ahead of print. JAMA. 2026. PMID: 42307937
Appendix Mucinous Neoplasm.
Xiao P, Xu T, Zhou M, Lei Z. Xiao P, et al. Among authors: zhou m. Clin Case Rep. 2026 Jun 30;14(7):e72939. doi: 10.1002/ccr3.72939. eCollection 2026 Jul. Clin Case Rep. 2026. PMID: 42389039 Free PMC article.
Longitudinal associations of cumulative and repeated-measure patterns of insulin resistance surrogate indices with biological age acceleration and incident cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0-3: evidence from CHARLS 2011-2020.
Han SS, Liu Q, Zhou MQ, Liu Y, Guo TT, Hu YK, Gao TA, Zeng ZM. Han SS, et al. Among authors: zhou mq. Cardiovasc Diabetol. 2026 May 16;25(1):198. doi: 10.1186/s12933-026-03206-z. Cardiovasc Diabetol. 2026. PMID: 42143308 Free PMC article.
Sensory nerves protect against preclinical tendinopathic changes through FGF1 signaling.
Zhu M, Xing X, Li Z, Du B, Xu M, Zhou M, Shi M, Qin Q, Archer M, Rao C, Cherief M, Ramesh S, Thottappillil N, Pagani CA, Somatilaka BN, Cao X, Levi B, Guan Y, James AW. Zhu M, et al. Among authors: zhou m. Sci Transl Med. 2026 May 13;18(849):eaec1380. doi: 10.1126/scitranslmed.aec1380. Epub 2026 May 13. Sci Transl Med. 2026. PMID: 42127222
Insig1 deficiency protects against acute kidney injury via targeting Dapk3.
Cao S, Wang Q, Zhou M, Sun Z, Sun L, Zhu W, Wang X, Huang S, Zhang A, Hua H, Ding G, Zhang Y, Jia Z. Cao S, et al. Among authors: zhou m. J Adv Res. 2026 May 16:S2090-1232(26)00431-5. doi: 10.1016/j.jare.2026.05.036. Online ahead of print. J Adv Res. 2026. PMID: 42144057 Free article.
21,875 results
You have reached the last available page of results. Please see the User Guide for more information.